Exact Sciences Gains as TD Cowen Sees 25% Price Hike for Next-gen Cologuard
Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts
5 analysts have expressed a variety of opinions on Exact Sciences (NASDAQ:EXAS) over the past quarter, offering a diverse set of opinions from bullish to bearish.Summarizing their recent assessments,
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threatens to undermine confidence the research abilities of the Darmstadt, Ger
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Citigroup r
Exact Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/26/2024 63.74% BTIG $80 → $70 Maintains Buy 05/09/2024 87.13% BTIG $85 → $80 Maintains Buy 05/09/2024 9
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 25, 2024
GAINERS:Global Hemp Group (OTC:GBHPF) shares closed up 29.87% at $0.03Target Group (OTC:CBDY) shares closed up 15.79% at $0.00Body and Mind (OTC:BMMJ) shares closed up 14.14% at $0.05Kaya Holdings (OT
am00se : how to know our tp master
potsy52 am00se: Don’t ask tp/ he’ll let you know when good time to sell